Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mavligit

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Archives of Surgery (Chicago, Ill. : 1960)|September 1, 1980
Arteriovenous carcinoembryonic antigen gradient: determination by selective angiography for localization of metastatic colorectal cancerY Z Patt, G Mavligit, V P Chuang, et al.
Progress in Experimental Tumor Research|January 1, 1974
Tumor-directed immune reactivity and immunotherapy in malignant melanoma. Current statusG Mavligit, J U Gutterman, C McBride, et al.
Cancer|April 1, 1979
Actinomycin-D, levamisole chemoimmunotherapy of refractory malignant melanomaS W Hall, R S Benjamin, U Lewinski, et al.
Cancer|August 1, 1973
BCG stimulation of immune responsiveness in patients with malignant melanoma. Preliminary reportJ Gutterman, G Mavligit, C McBride, et al.
Cancer|July 1, 1972
Hepatocellular carcinoma: presentation with vertebral metastases and radicular compressionM J Byrne, M A Scheinberg, G Mavligit, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|September 1, 1972
Multifaceted evaluation of human tumor immunity using a salt extracted colon carcinoma antigenG Mavligit, J U Gutterman, C M McBride, et al.
Annals of Internal Medicine|December 1, 1983
Human leukocyte interferon to control thrombocytosis in chronic myelogenous leukemiaM Talpaz, G Mavligit, M Keating, et al.
National Cancer Institute Monograph|December 1, 1973
Immunoprophylaxis of malignant melanoma with systemic BCG: study of strain, dose, and scheduleJ U Gutterman, G Mavligit, C McBride, et al.
Annals of the New York Academy of Sciences|January 1, 1979
New approaches to the evaluation of immunomodulation by thymic hormonesY Z Patt, E M Hersh, M Adebite, et al.
Journal of Biological Response Modifiers|August 1, 1986
A phase I study of intravenous azimexon therapy in human cancerY Z Patt, E M Hersh, J Reuben, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Archives of Surgery (Chicago, Ill. : 1960)|September 1, 1980
Arteriovenous carcinoembryonic antigen gradient: determination by selective angiography for localization of metastatic colorectal cancerY Z Patt, G Mavligit, V P Chuang, et al.
Progress in Experimental Tumor Research|January 1, 1974
Tumor-directed immune reactivity and immunotherapy in malignant melanoma. Current statusG Mavligit, J U Gutterman, C McBride, et al.
Cancer|April 1, 1979
Actinomycin-D, levamisole chemoimmunotherapy of refractory malignant melanomaS W Hall, R S Benjamin, U Lewinski, et al.
Cancer|August 1, 1973
BCG stimulation of immune responsiveness in patients with malignant melanoma. Preliminary reportJ Gutterman, G Mavligit, C McBride, et al.
Cancer|July 1, 1972
Hepatocellular carcinoma: presentation with vertebral metastases and radicular compressionM J Byrne, M A Scheinberg, G Mavligit, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|September 1, 1972
Multifaceted evaluation of human tumor immunity using a salt extracted colon carcinoma antigenG Mavligit, J U Gutterman, C M McBride, et al.
Annals of Internal Medicine|December 1, 1983
Human leukocyte interferon to control thrombocytosis in chronic myelogenous leukemiaM Talpaz, G Mavligit, M Keating, et al.
National Cancer Institute Monograph|December 1, 1973
Immunoprophylaxis of malignant melanoma with systemic BCG: study of strain, dose, and scheduleJ U Gutterman, G Mavligit, C McBride, et al.
Annals of the New York Academy of Sciences|January 1, 1979
New approaches to the evaluation of immunomodulation by thymic hormonesY Z Patt, E M Hersh, M Adebite, et al.
Journal of Biological Response Modifiers|August 1, 1986
A phase I study of intravenous azimexon therapy in human cancerY Z Patt, E M Hersh, J Reuben, et al.
Pageof 5